Business Description
Celadon Pharmaceuticals PLC
ISIN : GB00BDQYGP38
Compare
Compare
Traded in other countries / regions
CEL.UK IPO Date
2022-03-29Description
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 1.97 | |||||
| Debt-to-EBITDA | -1.1 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -5.74 | |||||
| Beneish M-Score | -3.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -125.4 | |||||
| 3-Year EPS without NRI Growth Rate | -82.3 | |||||
| 3-Year FCF Growth Rate | -98.7 | |||||
| 3-Year Book Growth Rate | 190.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.25 | |||||
| 9-Day RSI | 49.85 | |||||
| 14-Day RSI | 46.34 | |||||
| 6-1 Month Momentum % | -83.11 | |||||
| 12-1 Month Momentum % | -88.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.92 | |||||
| Quick Ratio | 1.41 | |||||
| Cash Ratio | 0.02 | |||||
| Days Sales Outstanding | 1033.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -14.06 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 346.92 | |||||
| Operating Margin % | -3793.85 | |||||
| Net Margin % | -4024.62 | |||||
| FCF Margin % | -4418.46 | |||||
| ROE % | -182.53 | |||||
| ROA % | -57.83 | |||||
| ROIC % | -63.51 | |||||
| ROC (Joel Greenblatt) % | -74.45 | |||||
| ROCE % | -61.3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 87.5 | |||||
| PB Ratio | 4.73 | |||||
| Price-to-Tangible-Book | 5.83 | |||||
| EV-to-EBIT | -3.44 | |||||
| EV-to-EBITDA | -3.89 | |||||
| EV-to-Revenue | 129.5 | |||||
| EV-to-FCF | -2.93 | |||||
| Earnings Yield (Greenblatt) % | -29.03 | |||||
| FCF Yield % | -47.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celadon Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.13 | ||
| EPS (TTM) (£) | -0.082 | ||
| Beta | 0 | ||
| Volatility % | 196.09 | ||
| 14-Day RSI | 46.34 | ||
| 14-Day ATR (£) | 0.036233 | ||
| 20-Day SMA (£) | 0.16105 | ||
| 12-1 Month Momentum % | -88.89 | ||
| 52-Week Range (£) | 0.11 - 1.225 | ||
| Shares Outstanding (Mil) | 68.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Celadon Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Celadon Pharmaceuticals PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Celadon Pharmaceuticals PLC Frequently Asked Questions
What is Celadon Pharmaceuticals PLC(LSE:CEL)'s stock price today?
The current price of LSE:CEL is £0.18. The 52 week high of LSE:CEL is £1.23 and 52 week low is £0.11.
When is next earnings date of Celadon Pharmaceuticals PLC(LSE:CEL)?
The next earnings date of Celadon Pharmaceuticals PLC(LSE:CEL) is 2025-05-14 Est..
Does Celadon Pharmaceuticals PLC(LSE:CEL) pay dividends? If so, how much?
Celadon Pharmaceuticals PLC(LSE:CEL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers